Literature DB >> 21798970

Biologicals for rheumatoid arthritis.

Peter Tugwell1, Jasvinder A Singh, George A Wells.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798970     DOI: 10.1136/bmj.d4027

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Jasvinder A Singh; Chris Cameron; Shahrzad Noorbaloochi; Tyler Cullis; Matthew Tucker; Robin Christensen; Elizabeth Tanjong Ghogomu; Doug Coyle; Tammy Clifford; Peter Tugwell; George A Wells
Journal:  Lancet       Date:  2015-05-11       Impact factor: 79.321

2.  Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol.

Authors:  Anna Dossing; Simon Tarp; Daniel E Furst; Christian Gluud; Joseph Beyene; Bjarke B Hansen; Henning Bliddal; Robin Christensen
Journal:  BMJ Open       Date:  2014-09-26       Impact factor: 2.692

3.  Design and implementation of a decision aid for juvenile idiopathic arthritis medication choices.

Authors:  William B Brinkman; Ellen A Lipstein; Janalee Taylor; Pamela J Schoettker; Katherine Naylor; Karla Jones; Sheetal S Vora; Catherine C Mims; Elizabeth Roth-Wojcicki; Beth Gottlieb; Nancy Griffin; Carole Lannon; Esi Morgan
Journal:  Pediatr Rheumatol Online J       Date:  2017-06-05       Impact factor: 3.054

4.  Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study.

Authors:  Anton Wulf Christensen; Simon Tarp; Daniel E Furst; Anna Døssing; Kirstine Amris; Henning Bliddal; Peter C Taylor; Robin Christensen
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.